Healthtech funding in 2016
European Healthtech startup funding raised during 2016.
In 2016, 327 European Healthtech companies closed 349 funding rounds and raised €1.9B in equity funding (excluding debt and grants). Debt rounds added €38M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 18 Nov 2026.
Equity funding
€1.9B
excl. debt & grants · +€38M debt
Funding rounds
349
Companies
327
Top country
UK
Healthtech: last three years
change vs the year before| Year | Equity | Change | Rounds | Change | Debt |
|---|---|---|---|---|---|
| 2014 | €928M | +47.1% | 134 | +10.7% | €649k |
| 2015 | €1.8B | +89.5% | 228 | +70.1% | €103M |
| 2016 | €1.9B | +9.2% | 349 | +53.1% | €38M |
Rank among sectors
#4
8.2% of sector funding
Debt financing
€38M
1.9% of total
Top-10 round share
29.4%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2016 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €91M | 23 |
| Feb | €144M | 24 |
| Mar | €87M | 23 |
| Apr | €279M | 27 |
| May | €249M | 39 |
| Jun | €222M | 33 |
| Jul | €181M | 26 |
| Aug | €34M | 17 |
| Sep | €182M | 30 |
| Oct | €257M | 43 |
| Nov | €153M | 36 |
| Dec | €110M | 28 |
Top countries
by € raisedHealthtech — top countries by capital, 2016 — interactive chart.
Data table
| Healthtech — top countries by capital, 2016 | |
|---|---|
| UK | €374M |
| Switzerland | €326M |
| France | €241M |
| Israel | €202M |
| Ireland | €188M |
| Sweden | €158M |
| Germany | €138M |
| Netherlands | €82M |
Stage mix
by € raisedHealthtech — stage mix, 2016 — interactive chart.
Data table
| Healthtech — stage mix, 2016 | |
|---|---|
| Growth/Late | €604M |
| Series A | €510M |
| Series B | €281M |
| Early VC | €185M |
| Seed | €115M |
| Series C | €103M |
| Series D+ | €89M |
| Debt | €38M |
| Other | €34M |
| Grant | €31M |
Exits & M&A
24 Acquisition · 4 IPO · 2 Merger30 exits · €1.9B disclosed.
| Arcam | Acquisition | Feb 2016 | €636M |
| Valtech Cardio | Acquisition | Apr 2016 | €628M |
| EngMab | Acquisition | May 2016 | €545M |
| Creo Medical | IPO | Jul 2016 | €74M |
| Genesort | Acquisition | Dec 2016 | €21M |
| Luck Genome | Acquisition | Oct 2016 | €11M |
Largest equity rounds
by disclosed amount, 2016| Company | Stage | Date | Amount |
|---|---|---|---|
| Oxford Nanopore Technologies | Growth/Late | Apr 2016 | €111M |
| MindMaze | Growth/Late | Feb 2016 | €92M |
| Carrick Therapeutics | Series A | Oct 2016 | €86M |
| F2G | Growth/Late | Jun 2016 | €55M |
| NaPopravku | Early VC | Dec 2016 | €46M |
| Brillen.de | Growth/Late | Jul 2016 | €45M |
| IOmx Therapeutics | Series A | Sep 2016 | €40M |
| AC Immune | Series D+ | May 2016 | €40M |
| Genomics Medicine Ireland | Series A | Oct 2016 | €36M |
| CRISPR Therapeutics | Series B | Jun 2016 | €35M |
Largest debt rounds
debt financing, 2016; not in the equity total| Company | Stage | Date | Amount |
|---|---|---|---|
| Neuravi | Debt | Nov 2016 | €15M |
| G-Therapeutics | Debt | Apr 2016 | €10M |
| Genesis Automation | Debt | Feb 2016 | €6.0M |
| Ixaltis | Debt | May 2016 | €2.8M |
| EnXray | Debt | Oct 2016 | €1.8M |
Top investors
most active in 2016, by deal count- High-Tech Gründerfonds (HTGF)11 deals
- Bpifrance10 deals
- Bayern Kapital6 deals
- Boehringer Ingelheim Venture Fund6 deals
- Capricorn Partners5 deals
- Seventure Partners5 deals
- Sunstone Capital5 deals
- Wellington Partners5 deals
- Innogest Capital4 deals
- LSP4 deals
Source: Tech.eu Funding Explorer · data as of 18 Nov 2026 · licence CC BY 4.0 · Methodology